PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy | MicrobiomeTrials← Back to trialsNCT07463248
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-15Est. Completion: 2028-01-31
Enrollment target: 64 participants Locations- West China Hospital, Chengdu, Sichuan, China
Other microbiome trials you might be interested in
Hepatocellular CarcinomaLiver Cancer, AdultLiver NeoplasmMetastatic Liver Cancer
This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT20…
Duarte, United StatesEst. completion Dec 31, 2027
Hepatocellular Carcinoma
The purpose of the study is to evaluate the efficacy of ZG005 combined with bevacizumab compared with sintilimab combine…
Nanjing, ChinaEst. completion Sep 2031
HCC - Hepatocellular Carcinoma
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving system…
Al Mansurah, EgyptEst. completion Dec 15, 2027